Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status
DTIL(NASDAQ:DTIL) DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced that it will be issued U.S. Patent No. 12,410,418 by the U.S. Patent and Trademark Office on September 9, 2025, titled “Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B Virus genome.” The compos
Quantiphi Granted Patent for Key Feature in Loss Run Processing for AI-powered Document Processing Platform, Dociphi
MARLBOROUGH, Mass., Aug. 26, 2025 /PRNewswire/ -- Quantiphi, an award-winning AI-first digital engineering company, has been granted a patent by the United States Patent and Trademark Office (USPTO) for a key feature within Dociphi, Quantiphi's generative AI-powered intelligent document...
Unicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney Disease
Ensures Intellectual Property Protection Until 2040
Ensures Intellectual Property Protection Until 2040
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy
Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cells
Harm Reduction Pioneer Challenges Patent Attempt on Century-Old Drug Testing Methods
HRDS LLC and Emanuel Sferios call for maintaining open-source access to lifesaving overdose prevention technology for psychedelics and opioids Patent application by German startup Miraculix threatens to monopolize harm reduction tools based on established scientific methods ALBUQUERQUE, N....
Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its AI-Based Athlete Data Simulation System that Leverages Synthetic Biological Data to Predict Future Events
SD LabsCLEVELAND--(BUSINESS WIRE)-- #AI--SD Labs has a new US patent for a novel AI-based system that generates synthetic biological data to simulate biological processes in athletes.
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
NAOVTYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ENvue Medical Holdings LLC division (“ENvue Medical” or “ENvue”), a new U.S. patent for its pediatric feeding tube guidance system. U.S. Patent No. 12,324,632, titled “Insertion Device Positioning Guidance System,” further strengthens ENvue Medical’s intellectual property portfolio and reflects the Comp
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
ENVBCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering compositions of matter and methods of use for a novel class of aminated tryptamine derivatives. The patented compounds were
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that the Japan Patent Office has issued a patent for another set of biomarkers in the company’s IP portfolio.
MIT Startup TechNext Awarded Patent for Breakthrough Technology Forecasting System
ARLINGTON, Va.--(BUSINESS WIRE)--Is your R&D flying blind? MIT startup TechNext forecasts winning tech, taking the guesswork out of a $2T global spend.
